FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher ...

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...

FibroGen has agreed to pay $1.25 million to the Securities and Exchange Commission (SEC) to address allegations that the ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

From undeclared allergens to contamination with salmonella or lead, herbs and spices have triggered some of the most serious ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be ...

In a statement to SFGATE, a Walgreens official confirmed that many adults under 65 do not need a prescription if they want ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic ...

Ultimately, in consultation with her oncologist, Katie selected ALUNBRIG ® (brigatinib) as her first-line treatment option, ...

Are additives and other ingredients added to many processed foods actually bad for your gut? find out what the research says ...